Redeye expects to leave its estimates largely unchanged - the Q3 2022 financials were in line with o...
Långa ledtider och försiktiga investeringsbudgetar hos telekomoperatörerna, i kombination med en öka...
Redeye argues that Sedana Medical may be up against a more challenging sales ramp-up than we previou...
Relais announced today that it will do the transition from Finnish Accounting Standards (FAS) to IFR...
Redeye reiterate our Base Case valuation at SEK 28 with a fair value range between SEK19 to SEK33.
Redeye comments on GiG ahead of its Q3-results (due 9 November) where we expect continued growth and...
Redeye raises its long-term estimates but maintains its fair value range unchanged on the back of th...
Redeye adjusts our near-term forecasts and our valuation following the Q3 report and the recent shar...
Occupancy rate +180 bps since Q3’21 to ~93% Management remains cautious on property valuation ~55%...
Sales +8% y-o-y, but EBIT declined y-o-y ‘22e-’24e EBIT cut by 28-46% on lower utilisation Well-po...
Bra fart i Q3 och orderboken växer snabbare Nettoomsättningen i det tredje kvartalet steg till 7,2 m...
Q3’22 i linje med tidigare annonserad resultatuppdatering BE Group presenterade EBIT för Q3’22 om 40...
Mgmt. guides for net letting to hold up well in Q4 Neg.
Beat across the board, sales up 22% q-o-q Estimates up, but we are cautious to extrapolate fully T...
Industrial printer eMELT announced today eMELT to be presented at Formnext 15-18 November First de...
Redeye reiterates its positive stance to Nexstim following last week’s Q3 update.
Raute’s Q3 figures were encouraging, and although profitability may still be muted for a few quarter...
Verkkokauppa.com publishes its Q3 result on Thursday, 28th Oct.
Redeye is encouraged to see that Freemelt is about to launch its 3D printer for industrial use (eMEL...
Redeye states its view on Hoylu’s Q3 2022 report, announced earlier today.
